Skip to main content
Erschienen in: Archives of Dermatological Research 5/2023

29.11.2022 | SHORT REPORT

Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case series

verfasst von: Hadir Shakshouk, Julia S. Lehman, Bicong Wu, Michi M. Shinohara, Simone Ince, Eric Xia, Arash Mostaghimi, Alex G. Ortega‐Loayza

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Pyoderma gangrenosum (PG) can represent a diagnostic challenge, leading to missed or delayed diagnosis. With prolonged immunosuppressive therapy, the risk of infections is elevated, predisposing patients to receive anti-infective treatments and, in serious cases, amputations. Limb amputations have been reported as complication of PG misdiagnosis but can also occur as a complication of long-standing PG ulcers.

Methods

We aimed to describe the clinical characteristics of patients with PG leading to limb amputation through a multicenter retrospective case series between 2010 and 2020 including patients with PG who underwent limb amputation. We report a descriptive analysis of these patients’ clinical course and outcome.

Results

Ten patients with PG who underwent at least one limb amputation were identified. Six were male (60%). Mean age was 65 years. All patients had ulcerative PG on the lower extremities, with a mean PG ulcer duration of 30.6 months. Six patients had PG-related comorbidities such as ulcerative colitis, myelodysplasia, and inflammatory arthritis. Other significant comorbidities included diabetes mellitus (DM) (five patients), coronary artery disease (five patients), and chronic kidney disease (two patients). The majority of patients (8/10) were correctly diagnosed with PG prior to amputation, whereas two patients were misdiagnosed with necrotizing soft tissue infections (NSTIs). All patients received intravenous antibiotics without substantial improvement. Eight patients developed sepsis and shock-like symptoms and the diagnosis of NSTIs was considered. Below-knee amputation was performed in six patients and above-knee amputation in four. Four patients had amputation performed twice because of recurrent NSTIs.
Conclusion This multicenter case series sheds light on practice gaps for physician assessing patients with PG, in that limb amputation may result from PG misdiagnosis or complications thereof. Elderly patients (above 65 years) with coexisting lower extremity PG, DM, and/or chronic cardiac or renal disease should be managed with particular care toward preventing infection/NSTIs to prevent further complications such as limb amputations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Barańska-Rybak W, Kakol M, Naesstrom M, Komorowska O, Sokołowska-Wojdyło M, Roszkiewicz J (2011) A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply. Am Surg 77(12):1644–1649CrossRefPubMed Barańska-Rybak W, Kakol M, Naesstrom M, Komorowska O, Sokołowska-Wojdyło M, Roszkiewicz J (2011) A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply. Am Surg 77(12):1644–1649CrossRefPubMed
3.
Zurück zum Zitat Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79(1):37–46CrossRefPubMed Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79(1):37–46CrossRefPubMed
4.
Zurück zum Zitat Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250CrossRefPubMed Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250CrossRefPubMed
5.
Zurück zum Zitat Cirotteau P, Heron-Mermin D, Dimicoli-Salazar S, Gérard E, Leroy H, Clément L, Beylot-Barry M (2019) Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? J Eur Acad Dermatol Venereol 33(8):e305–e306CrossRefPubMed Cirotteau P, Heron-Mermin D, Dimicoli-Salazar S, Gérard E, Leroy H, Clément L, Beylot-Barry M (2019) Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? J Eur Acad Dermatol Venereol 33(8):e305–e306CrossRefPubMed
6.
Zurück zum Zitat Gavioli EM, Casias M, Ngo L (2020) Pyoderma gangrenosum and superimposed infection: a case report. Adv Skin Wound Care 33(6):1–3CrossRefPubMed Gavioli EM, Casias M, Ngo L (2020) Pyoderma gangrenosum and superimposed infection: a case report. Adv Skin Wound Care 33(6):1–3CrossRefPubMed
7.
Zurück zum Zitat Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG (2021) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol 141(1):59–63CrossRefPubMed Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG (2021) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol 141(1):59–63CrossRefPubMed
8.
Zurück zum Zitat Haag CK, Nutan F, Cyrus JW, Satpathy J, Shinkai K, Ortega Loayza AG (2019) Pyoderma gangrenosum misdiagnosis resulting in amputation: a review. J Trauma Acute Care Surg 86(2):307–313CrossRefPubMed Haag CK, Nutan F, Cyrus JW, Satpathy J, Shinkai K, Ortega Loayza AG (2019) Pyoderma gangrenosum misdiagnosis resulting in amputation: a review. J Trauma Acute Care Surg 86(2):307–313CrossRefPubMed
9.
Zurück zum Zitat Jemec GB, Konradsen L (1994) Pyoderma gangrenosum complicated by necrotizing fasciitis. Cutis 53(3):139–141PubMed Jemec GB, Konradsen L (1994) Pyoderma gangrenosum complicated by necrotizing fasciitis. Cutis 53(3):139–141PubMed
10.
Zurück zum Zitat Jockenhöfer F, Klode J, Kröger K, Roesch A, Al Ghazal P, Dissemond J (2016) Patients with pyoderma gangrenosum: analyses of the German DRG data from 2012. Int Wound J 13(5):951–956CrossRefPubMed Jockenhöfer F, Klode J, Kröger K, Roesch A, Al Ghazal P, Dissemond J (2016) Patients with pyoderma gangrenosum: analyses of the German DRG data from 2012. Int Wound J 13(5):951–956CrossRefPubMed
11.
Zurück zum Zitat Nawijn F, Smeeing DPJ, Houwert RM, Leenen LPH, Hietbrink F (2020) Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg 15:4CrossRefPubMedPubMedCentral Nawijn F, Smeeing DPJ, Houwert RM, Leenen LPH, Hietbrink F (2020) Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg 15:4CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, Ortega-Loayza AG, Cohen J, McCalmont TH, Demer AM et al (2019) Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol 155(1):79–84CrossRefPubMed Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, Ortega-Loayza AG, Cohen J, McCalmont TH, Demer AM et al (2019) Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol 155(1):79–84CrossRefPubMed
14.
Zurück zum Zitat Weenig RH, Davis MD, Dahl PR, Su WP (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 347(18):1412–1418CrossRefPubMed Weenig RH, Davis MD, Dahl PR, Su WP (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 347(18):1412–1418CrossRefPubMed
15.
Zurück zum Zitat Xia FD, Liu K, Lockwood S, Butler D, Tsiaras WG, Joyce C, Mostaghimi A (2018) Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 78(2):310-314.e311CrossRefPubMed Xia FD, Liu K, Lockwood S, Butler D, Tsiaras WG, Joyce C, Mostaghimi A (2018) Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 78(2):310-314.e311CrossRefPubMed
Metadaten
Titel
Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case series
verfasst von
Hadir Shakshouk
Julia S. Lehman
Bicong Wu
Michi M. Shinohara
Simone Ince
Eric Xia
Arash Mostaghimi
Alex G. Ortega‐Loayza
Publikationsdatum
29.11.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 5/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02484-3

Weitere Artikel der Ausgabe 5/2023

Archives of Dermatological Research 5/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.